Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 1
1987 3
1988 2
1989 6
1990 6
1991 3
1992 6
1993 9
1994 8
1995 9
1996 13
1997 20
1998 15
1999 22
2000 17
2001 21
2002 25
2003 42
2004 50
2005 60
2006 52
2007 70
2008 111
2009 149
2010 186
2011 229
2012 194
2013 261
2014 254
2015 281
2016 338
2017 434
2018 461
2019 607
2020 729
2021 817
2022 747
Text availability
Article attribute
Article type
Publication date

Search Results

5,582 results
Results by year
Filters applied: . Clear all
Page 1
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
D'Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, Ferrante M. D'Haens G, et al. Among authors: liao x. Lancet. 2022 May 28;399(10340):2015-2030. doi: 10.1016/S0140-6736(22)00467-6. Lancet. 2022. PMID: 35644154 Clinical Trial.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Ferrante M, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, Dubinsky M, Feagan BG, Hisamatsu T, Lim A, Lindsay JO, Loftus EV Jr, Panés J, Peyrin-Biroulet L, Ran Z, Rubin DT, Sandborn WJ, Schreiber S, Neimark E, Song A, Kligys K, Pang Y, Pivorunas V, Berg S, Duan WR, Huang B, Kalabic J, Liao X, Robinson A, Wallace K, D'Haens G. Ferrante M, et al. Among authors: liao x. Lancet. 2022 May 28;399(10340):2031-2046. doi: 10.1016/S0140-6736(22)00466-4. Lancet. 2022. PMID: 35644155 Clinical Trial.
Hypernatremia in brain-dead patients.
Guo W, Wang S, Wang Z, Hu P, Wei X, Liao X. Guo W, et al. Among authors: liao x. Brain Behav. 2022 May;12(5):e2574. doi: 10.1002/brb3.2574. Epub 2022 Apr 22. Brain Behav. 2022. PMID: 35452564 Free PMC article.
5,582 results